A survey of COVID-19 vaccine acceptance across 23 countries in 2022
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
复制标题
DOI：
10.1038/s41591-022-02185-4
复制
发表时间：
2023-01-09
期刊：
影响因子：
82.9
通讯作者：
El-Mohandes, Ayman
中科院分区：
文献类型：
--
作者：
Lazarus, Jeffrey V.;Wyka, Katarzyna;El-Mohandes, Ayman
2022年，尽管引入了安全有效的疫苗和药物，严重急性呼吸系统综合征冠状病毒2型（SARS-CoV-2）继续变异和传播。疫苗犹豫仍然很大，部分原因是错误信息。我们的第三项冠状病毒疾病研究2019 23个国家的23，000名受访者对新冠肺炎疫苗犹豫不决（巴西、加拿大、中国、厄瓜多尔、法国、德国、加纳、印度、意大利、肯尼亚、墨西哥、尼日利亚、秘鲁、波兰、俄罗斯、新加坡、南非、韩国、西班牙、瑞典、土耳其、联合王国和美国），2022年6月29日至7月10日的调查发现，接受疫苗接种的意愿为79.1%，较2021年6月上升5.2%。然而，8个国家的犹豫增加，从1.0%（联合王国）到21.1%（南非）不等。几乎八分之一（12.1%）的接种疫苗的受访者对加强剂量犹豫不决。对18岁以下儿童接种疫苗的总体支持略有增加，但在个人犹豫不决的父母中有所下降。近五分之二（38.6%）的受访者表示，他们对新冠肺炎信息的关注程度低于以往，对疫苗接种授权的支持也有所下降。近四分之一（24%）的患病者报告说，他们正在服用药物来对抗COVID-19症状。疫苗接种仍然是应对COVID-19大流行的基石，但广泛的公众支持仍然难以实现。这些数据可供卫生系统决策者、从业者、倡导者和研究人员使用，以更有效地解决COVID-19疫苗犹豫问题。
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine hesitancy remains substantial, fueled in part by misinformation. Our third study of Coronavirus Disease 2019 (COVID-19) vaccine hesitancy among 23,000 respondents in 23 countries (Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Turkey, the United Kingdom and the United States), surveyed from 29 June to 10 July 2022, found willingness to accept vaccination at 79.1%, up 5.2% from June 2021. Hesitancy increased in eight countries, however, ranging from 1.0% (United Kingdom) to 21.1% (South Africa). Almost one in eight (12.1%) vaccinated respondents are hesitant about booster doses. Overall support for vaccinating children under 18 years of age increased slightly but declined among parents who were personally hesitant. Almost two in five (38.6%) respondents reported paying less attention to new COVID-19 information than previously, and support for vaccination mandates decreased. Almost a quarter (24%) of those who became ill reported taking medications to combat COVID-19 symptoms. Vaccination remains a cornerstone of the COVID-19 pandemic response, but broad public support remains elusive. These data can be used by health system decisionmakers, practitioners, advocates and researchers to address COVID-19 vaccine hesitancy more effectively.